13 May 2011

Brain Tumour Support and Education Forum 2011

Institute events
Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn
Brain Tumour Support and Education Forum 2011

The 2011 forum featured International Guest Speaker, Associate Professor David Reardon, as well as leading local clinicians across the spectrum of care presenting patient-focussed education sessions covering all aspects of the patient journey. The day culminated with a dedicated Q&A session facilitated by ABC science journalist Robyn Williams and featuring neurosurgeon Dr Charlie Teo.

Brain Cancer Action Week: Ideas. Research. Hope.The Brain Tumour Support and Education Forum was hosted by NSW Oncology Group (NSWOG) Neuro-Oncology as part of the 2011 Brain Cancer Action Week and was streamed live via a synchronised video and slideshow webcast. Recordings of the live webcasts are provided below.

Get Microsoft SilverlightThese videos will open in a new window, and require the free Microsoft Silverlight plugin to be installed.

Please send us your feedback

We hope you benefit from watching the forum via these webcast recordings. We invite you to provide feedback on how useful and effective this technology is by completing this short survey.

Welcome

Professor David Currow

Professor David Currow

Chief Cancer Officer and CEO, Cancer Institute NSW

Professor David Currow welcomed patients, carers and health professionals to the forum, and officially launched the Cancer Institute NSW Brain tumour nursing module.

Watch the video

Keynote address

Associate Professor David Reardon

Associate Professor David Reardon

Associate Deputy Director, Preston Robert Tisch Brain Tumour Center, Duke University Medical Center, North Carolina, USA

International Guest Speaker, Associate Professor David Reardon provided a detailed overview of recent scientific advances and innovative treatments for brain tumours, their translation to the clinic and impact in improving outcomes. These promising therapeutic strategies included convection enhanced delivery, immunotherapy and anti-angiogenic agents.

Watch the video

Advances in neurosurgery

Dr Ben Jonker

Dr Ben Jonker

Neurosurgeon, Royal Prince Alfred Hospital

Neurosurgeon Dr Ben Jonker presented some of the advances in neurosurgery, including the technology used to make surgery safer and more effective - and the associated benefits and limitations of these. These included the use of preoperative imaging, interoperative imaging, intraoperative functional assessments, stereotactic radiosurgery and combined approaches.

Watch the video

Advances in radiotherapy and re-irradiation

Associate Professor Michael Back

Associate Professor Michael Back

Director of Radiation Oncology, Northern Sydney Cancer Centre

Associate Professor Michael Back spoke of the technological advances in radiotherapy, including improvements in localising the tumour, supporting accurate design, avoiding healthy brain and ensuring delivery systems are reliable and safe. The presentation included education on delivering higher radiation doses and approaches to re-irradiation.

Watch the video

Chemotherapy

Professor Anna Nowak

Professor Anna Nowak

Medical Oncologist, Sir Charles Gairdner Hospital, WA

Professor Nowak used simple language to describe chemotherapy and what happens on a day to day basis, including why chemotherapy is needed. The session also included a detailed look at two different chemotherapy agents - Temozolomide and Bevacizumab (Avastin).

Watch the video

Rehabilitation

Associate Professor Andrew Cole

Associate Professor Andrew Cole

Chief Medical Officer, HammondCare and Hope Healthcare

After addressing some of the effects of brain tumours, Associate Professor Andrew Cole presented important factors to "get going" after a brain tumour - including getting back to driving and getting back to work.

Watch the video

Clinical trials

Dr Elizabeth Hovey and Associate Professor David Reardon

Dr Elizabeth Hovey

Senior Staff Specialist, Medical Oncology, Prince of Wales Hospital; and

Associate Professor David Reardon

Associate Deputy Director, Preston Robert Tisch Brain Tumour Center, Duke University Medical Center, North Carolina, USA

To give both the local and international perspective to clinical trials, Medical Oncologist Dr Elizabeth Hovey teamed with International Guest Associate Professor David Reardon to present an overview of the different types and phases of studies and associated patient rights and consent.

Watch the video

Launch of clinical practice guidelines

Professor Michael Barton

Professor Michael Barton

Professor of Radiation Oncology, University of New South Wales

Clinical practice guidelines Adult Gliomas (astrocytomas and oligodendrogliomas) a guide for patients, their families and carers are now available online.

View the clinical practice guidelines.

Watch the video

Expert panel question and answer session

An panel of experts addressed patient questions in a dedicated Q&A session moderated by science journalist and ABC broadcaster, Robyn Williams.

Expert panel (L-R): Robyn Williams, Professor Skye McDonald, Associate Professor David Reardon, Dr Charlie Teo, Dr Helen Wheeler, Marina Kastelan, Professor Michael Barton and Laraine Cross

Expert panel (from left to right): Robyn Williams, Professor Skye McDonald, Professor, School of Psychology, University of NSW; Associate Professor David Reardon (keynote speaker); Dr Charlie Teo, Director, Centre for Invasive Neurosurgery, Prince of Wales Private; Dr Helen Wheeler, Medical Oncologist, Royal North Shore; Marina Kastelan, Clinical Nurse Consultant, Northern Cancer Institute, North Shore Private Hospital; Professor Michael Barton, Professor of Radiation Oncology; Laraine Cross, Senior Clinician, Social Work, Calvary-Mater

Watch the video

 

Past forums

Read summaries and view video coverage of speakers from past forums:

Event details and registration

Date/Time 13 May 2011

Please note:
Events publicised on this website align to the goals and objectives of the NSW Cancer Plan 2011-2015, are evidence-based, not-for profit and are conducted by:

  • Professional colleges
  • Cancer councils
  • State-based, national and international cancer control organisations and agencies.
  • Cancer or health services
  • Government organisations
  • Academic institutions.

The Cancer Institute NSW will consider events that meet this criteria on a case-by-case basis, and will not support activities or groups that do not comply with strict evidence-based principles.

Top of page